Kalaris Therapeutics Statistics
Total Valuation
KLRS has a market cap or net worth of $76.31 million. The enterprise value is -$12.12 million.
Important Dates
The last earnings date was Wednesday, August 13, 2025, before market open.
Earnings Date | Aug 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KLRS has 18.70 million shares outstanding. The number of shares has increased by 92.38% in one year.
Current Share Class | 18.70M |
Shares Outstanding | 18.70M |
Shares Change (YoY) | +92.38% |
Shares Change (QoQ) | +361.40% |
Owned by Insiders (%) | 9.02% |
Owned by Institutions (%) | 8.60% |
Float | 4.31M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.44 |
P/TBV Ratio | 1.44 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.98
Current Ratio | 11.98 |
Quick Ratio | 11.56 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.71 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -79.34% |
Revenue Per Employee | n/a |
Profits Per Employee | -$5.83M |
Employee Count | 14 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.66% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -76.66% |
50-Day Moving Average | 2.62 |
200-Day Moving Average | 6.96 |
Relative Strength Index (RSI) | 81.23 |
Average Volume (20 Days) | 82,685 |
Short Selling Information
The latest short interest is 126,134, so 0.67% of the outstanding shares have been sold short.
Short Interest | 126,134 |
Short Previous Month | 110,792 |
Short % of Shares Out | 0.67% |
Short % of Float | 2.93% |
Short Ratio (days to cover) | 1.12 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -67.59M |
Pretax Income | n/a |
Net Income | -81.66M |
EBITDA | n/a |
EBIT | -67.59M |
Earnings Per Share (EPS) | -$6.99 |
Full Income Statement Balance Sheet
The company has $88.43 million in cash and n/a in debt, giving a net cash position of $88.43 million or $4.73 per share.
Cash & Cash Equivalents | 88.43M |
Total Debt | n/a |
Net Cash | 88.43M |
Net Cash Per Share | $4.73 |
Equity (Book Value) | 53.12M |
Book Value Per Share | 2.84 |
Working Capital | 84.00M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -32.16M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |